BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9548436)

  • 1. Up-regulation of p27Kip1 correlates inversely with anchorage-independent growth of human cancer cell lines.
    Kawada M; Uehara Y; Mizuno S; Yamori T; Tsuruo T
    Jpn J Cancer Res; 1998 Feb; 89(2):110-5. PubMed ID: 9548436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells.
    Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB
    Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
    Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
    Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
    St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
    J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
    Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
    Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.
    Kawada M; Yamagoe S; Murakami Y; Suzuki K; Mizuno S; Uehara Y
    Oncogene; 1997 Aug; 15(6):629-37. PubMed ID: 9264403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
    Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
    Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.